Assuming that the immunoreactivity score > 2.0 defined tumors with high SATB2-Ir, we found that IHC staining of SATB2 was absent or low in 30/104 (28.8%) and high in 74/104 (71.2%) CRC specimens (Table 2). This evidence concerns the gene SATB2 and colorectal carcinoma.